Blood Cancer – Leukaemia

Note: The information on cancer types on the ACRF website is not designed to provide medical or professional advice and is for information only. If you have any health problems or questions please consult your doctor. All statistics have been sourced from the Australian Institute of Health and Welfare.

Leukaemia Overview

Leukaemia is caused by the accumulation of excess, abnormal white blood cells. Leukaemias are grouped according to the type of white blood cell that is affected – either lymphoid or myeloid cells. They are the also classified according to the speed with which they can progress.

Leukaemia Types

Acute leukaemias occur when abnormal white blood cells rapidly multiply, spilling into the blood stream.  Acute leukaemias develop quickly and will need to be treated urgently as they crowd out healthy cells, leaving the body starved of oxygen, and unable to control disease or infection.

Chronic leukaemias develop more slowly. They occur when white blood cells fail to die, accumulating in the blood stream, bone marrow and related organs and crowding healthy cells. Chronic leukaemias may not require immediate treatment.

In Australia, more than 3200 people will be diagnosed with a form of leukaemia this year – that’s eight Australians per day.

Please click on the below for more information on the main sub-types of Leukaemia:

LATEST Leukaemia

Australian approval for drug that ‘melts’ leukaemia

A new anti-cancer drug with the power to ‘melt away’ certain advanced forms of chronic lymphocytic leukaemia (CLL) has been granted approval…

‘Cellular CCTV’ helps solve longstanding leukaemia mystery

Cancer researchers in Australia and the United Kingdom have answered the longstanding question of how leukaemia survives chemotherapy. These findings will help…

Venetoclax could target hard to treat childhood cancers

A newly approved adult leukaemia therapy called venetoclax could successfully target high-risk leukaemia subtypes in infants or children reveals an Australian study…

Cancer Research Discoveries | ACRF

Cancer immunity enhanced by natural killer cells

A team of researchers from Australia and France have uncovered new insights into how to prolong the lifespan of the body’s disease-fighting…

New ACT drug discovery platform

Today, Australian National University (ANU), the ACT Minister for Health and Australian Cancer Research Foundation (ACRF) will launch a new robotic system…

Aggressive prostate cancer linked to faulty BRCA2 gene

New research has revealed why men with a family history of prostate cancer, and who also carry the BRCA2 gene fault, have…